1Yu H,Rohan T. Role of the insulin-like growth factor family in cancer development and progression[J]. J Natl Cancer Inst, 2000,92(18) :1472-1489.
2Khandwala HM, McCutcheon IE, Flyvbjerg A, et al. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth[J]. Endocr Rev, 2000,21 (3) : 215-244.
3Baserga R, Peruzzi F, Reiss K. The IGF 1 receptor in cancer biology[J]. Int J Cancer,2003,107(6) :873-877.
4Stattin P, Rinaldi S, Biessy C, et al. High levels of circulating insulin-like growth factor-Ⅰ increase prostate cancer risk: a prospective study in a population-based nonscreened cohort [J]. J Clin Oncol,2004,22(15) :3104-3112.
5Renehan AG,Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-Ⅰ, IGF binding protein-3, and cancer risk: systematic review and rneta-regression analysis [J ]. Lancet, 2004,363(9418):1346-1353.
6Holdaway IM,Mason BH, Lethaby AE, et al. Serum insulin- like growth factor-Ⅰ and insulin-like growth factor binding protein 3 following chemotherapy for advanced breast cancer [J]. ANZ J Surg,2003,73(11) :905-908.
7Karey KP,Sirbasku DA. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol[J] Cancer Res, 1988,48(14) : 4083-4092.
8Furlanetto RW, Harwell SE, Frick KK. Insulin-like growth factor- Ⅰ induees cyclin-D1 expression in MG63 human osteosarcoma cells in vitro [ J ]. Mol Endocrinol, 1994,8 ( 4 ) : 510-517.
9Wu Y, Yakar S, Zhao L, et al. Circulating insulin like growth factor-Ⅰ levels regulate colon cancer growth and metastasis [J]. Cancer Res,2002,62(4) : 1030-1035.
10Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta 1 on programmed cell death through a p53- and IGF-independent mechanism[J]. J Biol Chem. 1997,272(18) : 12181-12188.
